Trial NCT02677948

View at ClinicalTrials.gov 
Org. Study IDs: UMCC 2015.131
Secondary IDs: HUM00105554

Last trial update was posted on 2017-09-06

MeSH Interventions

Ibrutinib

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Lymphoma

Other Conditions

Chronic Lymphocytic Leukemia Lymphoma, Small Lymphocytic

Stopping Reasons

FDA has placed all trials involving Pacritinib on Full Clinical Hold

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID